ACCC association of cancer care centers
Join/Renew
Login
Join/Renew
Login
Education & Resources
ACCC eXchange LogInCorporate Member Sponsored ResourcesPresentations & AbstractsPresident's ThemeACCC Connect eLearning LogIn
Publications
Oncology IssuesPatient Assistance & Reimbursement GuideTrending Now in Cancer Care
Events
2026 ACCC Leadership SummitAnnual Meeting & Cancer Center Business SummitCapitol Hill DayNational Oncology ConferenceOncology Reimbursement MeetingsOncology State Society Meetings
Policy & Advocacy
2024 Policy Wrap-Up and ACCC 2025 Policy PrioritiesLetters & StatementsAccess, Payment & Reimbursement ReformWhite Bagging & Brown BaggingAdvocacy ResourcesCancer Moonshot
Membership
Join | RenewWho We AreMembership Types & BenefitsCorporate MembersACCC Member Portal FAQMember Directory
Partners
Oncology State SocietiesPartner OrganizationsCME
News
News ReleasesAdvocacy News ReleasesOncology News
About ACCC
Timeline / 50th Anniversary2025 Impact ReportACCC Innovator AwardsACCC FellowsACCC Senior Staff
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
Join/Renew
Login
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
    • Education & Resources
    • Publications
    • Events
    • Policy & Advocacy
    • Membership
    • Partners
    • News
    • About ACCC
ACCC association of cancer care centers
1801 Research Boulevard, Suite 400, Rockville, MD 20850
Tel: 301.984.9496 Fax: 301.770.1949 Email Us
Contact UsVolunteers
Advertise
Career Center
Terms and Conditions
Privacy Policy
ACCC Rebranding
Copyright © 2026 Association of Cancer Care Centers. All Rights Reserved.
Home / Education And Resources / Patient Assistance And Reimbursement Guide / Companies / Gilead

GILEAD

Gilead

Patient and Reimbursement Assistance

https://www.gileadoncologysupport.com/

Phone Number

1.844.876.3358

Gilead offers Gilead Oncology Support for patients prescribed Trodelvy. Gilead Oncology Support is a patient support program that helps patients and healthcare providers understand the coverage and financial support options to access Trodelvy.

For more information, go to www.gileadoncologysupport.com or call 1.844.876.3358, Monday through Friday, 9:00 AM to 7:00 PM EST.

Oncology-related products: Trodelvy™ (sacituzumab govitecan-hziy) for injection


Patient Assistance Program

Gilead Oncology Support Patient Assistance Program

Patients who are uninsured may be eligible to obtain access to Trodelvy at no cost through the Gilead Patient Assistance Program. To qualify for assistance, patients must meet certain eligibility criteria.

To determine patient eligibility, submit an enrollment online at www.gileadoncologysupport.com or call 1.833.851.4344. A program specialist will contact the healthcare provider's office with determination of the patient’s eligibility.

For more information regarding the program, contact 1.844.876.3358, Monday through Friday, 9:00 AM to 7:00 PM EST.


Reimbursement Assistance

Gilead Oncology Support

Gilead Oncology Support is a patient access and reimbursement support program. Reimbursement support offerings include:

  • Coverage verification
  • Prior authorization information
  • Claims status information
  • Billing and coding information
  • Additional assistance options

For further information, contact the program at 1.844.876.3358, Monday through Friday, 9:00 AM to 7:00 PM EST.

Gilead Oncology Support information on additional assistance options

Gilead Oncology Support program specialists can provide patients who are unable to afford their medication (including those with Medicare, Medicaid, or other government-sponsored insurance) or need other resources with information about independent third-party organizations that may be able to help. Healthcare professionals or patients can call 1.844.876.3358, option 4, for more information.


Co-Pay Program

Gilead Oncology Support Co-Pay Program

Gilead Oncology Support provides savings on out-of-pocket expenses for patients prescribed Trodelvy for commercially or privately insured patients. Patients may pay as little as $0 out of pocket for Trodelvy, which includes co-pay and coinsurance, up to $25,000 annually.

Patients are responsible for cost share of other treatments and office visits. This program does not support any claims covered, paid, or reimbursed, in whole or in part, by Medicaid, Medicare, or other federal or state healthcare programs.

To enroll, enroll online at www.gileadoncologysupport.com or call 1.833.851.4344.

For further information, contact the program at 1.844.876.3358, Monday through Friday, 9:00 AM to 7:00 PM EST.

Oncology-related products: Trodelvy™ (sacituzumab govitecan-hziy) for injection


Patient Assistance Program

Gilead Patient Asssitance Program

Patients who are uninsured or underinsured may be eligible to obtain access to Trodelvy at no cost through the Gilead Patient Assistance Program. To qualify for assistance, patients must meet certain eligibility criteria.

To determine patient eligibility, fax a completed program enrollment form to 1.833.851.4344. A case manager will contact the healthcare provider's office with determination of the patient’s eligibility.

For more information regarding the program, contact 1.844.876.3358, Monday through Friday, 9:00 AM to 7:00 PM EST.


Reimbursement Assistance

Trodelvy Access Support

Trodelvy access support is a patient access and reimbursement support program. Reimbursement support services include:

  • Coverage verification
  • Prior authorization information
  • Claims status information
  • Billing and coding information
  • Alternate assistance options.

For further information, contact the program at 1.844.876.3358, Monday through Friday, 9:00 AM to 7:00 PM EST.


Independent Charitable Foundations/Organizations

Trodelvy Access Support Referrals

Trodelvy Access Support case managers can provide patients
who are unable to afford their medication (including those with
Medicare, Medicaid, or other government-sponsored insurance) with information about independent third-party organizations that may be able to help with the cost of treatment.

Healthcare professionals or patients can call 1.844.876.3358, option 4, for more information.


Co-Pay Card/Out-Of-Pocket Cost Assistance

Trodelvy Savings Program

The Trodelvy Savings Program provides savings on out-of-pocket expenses for Trodelvy for commercially or privately insured patients. Patients pay $0 out of pocket for Trodelvy, which includes co-pay and coinsurance, up to $25,000 annually.

Patients are responsible for cost share of treatments and office visits. This program does not support any claims covered, paid, or reimbursed, in whole or in part, by Medicaid, Medicare, or other federal or state healthcare programs.

To enroll, fax the completed enrollment form to 1.833.851.4344.

For further information, contact the program at 1.844.876.3358, Monday through Friday, 9:00 AM to 7:00 PM EST.